Sign in
4

Changes in Ownership

Caribou Biosciences, Inc. Filed Acc 0001754067-26-000002

Chief Technology Officer sold 3,147 shares at $1.96 ($6,168)

  • Chief Technology Officer acquired 45,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kelly Timothy P · Chief Technology Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-20 Grant or award : show line 1 in the form +45,000 82,500 D
2026-02-24 Sale : show line 2 in the form −3,147 $1.96 $6,168 79,353 D
Open-market sales · 3,147 sh · avg $1.96 · $6,168

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-20 Grant or award : show line 3 in the form Option to purchase Common Stock +202,500 202,500 D
Loading xslF345X05/wk-form4_1771984478.xml…